Page last updated: 2024-10-29
avapro and Venous Thrombosis
avapro has been researched along with Venous Thrombosis in 1 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Venous Thrombosis: The formation or presence of a blood clot (THROMBUS) within a vein.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Wang, YC | 1 |
Chuang, FR | 1 |
Lee, WC | 1 |
Chen, TC | 1 |
Ko, SF | 1 |
Wang, IK | 1 |
Lee, CH | 1 |
Other Studies
1 other study available for avapro and Venous Thrombosis
Article | Year |
---|---|
Low-molecular-weight heparin successfully used to treat a nephrotic patient complicated by superior mesenteric vein thrombosis and portal vein thrombosis.
Topics: Antihypertensive Agents; Biphenyl Compounds; Glucocorticoids; Heparin, Low-Molecular-Weight; Humans; | 2011 |